Radiopharmaceutical Therapy in Benign and Malignant Diseases: Radiotheragnostic Practicum 2021

Radiopharmaceutical Therapy in Benign and Malignant Diseases: Radiotheragnostic Practicum 2021

Regular price
$110.00
Sale price
$110.00

Topics:

History & Practice of Radioiodine Therapy in Hyperthyroidism

Mark Tulchinsky, M.D., FACNM, FSNMMI, CCD

Overview of Targeted Therapy - Lessons Learned

Terence Z. Wong, M.D., Ph.D.

 Radioiodine Therapy: Uncommon Benign Thyroid Conditions

Mark Tulchinsky, M.D., FACNM, FSNMMI, CCD

 I-131 Iobenguane Imaging & Therapy for Pheochromocytoma/Paraganglioma

Erik S. Mittra M.D., Ph.D.

 Radioiodine in Thyroid Cancer - Basics

Mark Tulchinsky, M.D., FACNM, FSNMMI, CCD

 Radioiodine in Thyroid Cancer - Advanced

Mark Tulchinsky, M.D., FACNM, FSNMMI, CCD

 Radioembolization Therapy with Y-90 Resin and Glass Microspheres

Terence Z. Wong, M.D., Ph.D.

 Ga-68/Lu-177 Dotatate Imaging/Therapy of Neuroendocrine Tumors

Erik S. Mittra M.D., Ph.D.

 Diagnostic Imaging of Recurrent and Metastatic Prostate Cancer

Samuel Mehr, M.D.

 Therapy for Skeletal Metastatic Disease with Bone-Seeking Agents

Terence Z. Wong, M.D., Ph.D.

Radiotheragnostics in Prostate Cancer

Terence Z. Wong, M.D., Ph.D.

 Pivotal Trials in the USA for Up-and-Coming Radiotheragnostics

Erik S. Mittra M.D., Ph.D.

 Opportunities for Somatostatin Receptor Targeting in Avid Cancers

Samuel Mehr, M.D.

Building Nuclear Medicine Therapy Program in Academic Practice

Erik S. Mittra M.D., Ph.D.

Building Nuclear Medicine Therapy Program in Private Practice

Samuel Mehr, M.D.